Electric wheelchair (HC819N, HC830N, HC831N)
Yongkang Hengyi Vehicle Co., Ltd. · Decision date Sep 8, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-08 for K260229, a traditional 510(k) submitted by Yongkang Hengyi Vehicle Co., Ltd. of Yongkang, CN, covering an electric wheelchair sold under model designations HC819N, HC830N and HC831N. The device falls under classification name Wheelchair, Powered, regulation number 890.3860, product code ITI, with the review panel and medical specialty listed as Physical Medicine. The application was received on 01/26/2026.
SESE means the submission was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The record shows the review was not conducted by a third party, the product was not a combination product, and no predetermined change control plan was authorized. The public record does not identify the predicate device, summarize the technological differences, or describe testing or clinical evidence, so the basis for the equivalence finding remains outside this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Physical Medicine
- Decision date
- Sep 8, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260229
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Yongkang Hengyi Vehicle Co., Ltd.
- Product code
- ITI
- Decision code
- SESE
- Decision date
- Sep 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Wheelchair, Powered.
- Applicant
- Yongkang Hengyi Vehicle Co., Ltd.
- Product code
- ITI
- FDA device class
- 2
FDA decision timeline
K260229 received
Application receipt date recorded by FDA.
K260229 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code ITI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| MAIKANG MEDICAL EQUIPMENT (HEBEI) CO., Ltd. | 510(k) clearance | Nov 6, 2026 | FDA | |
| Anhui Longway Medical Technology Co., Ltd. | 510(k) clearance | Oct 28, 2026 | FDA | |
| Anhui JBH Medical Apparatus Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Anhui JBH Medical Apparatus Co., Ltd. | 510(k) clearance | Oct 26, 2026 | FDA | |
Power Wheelchair (D39)K261169 | Anhui JBH Medical Apparatus Co., Ltd. | 510(k) clearance | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Yongkang Hengyi Vehicle Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Yongkang
Sources and methodology
- Original FDA record: K260229
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


